当前位置：首页 SCI期刊 SCIE期刊医学中科院3区 JCRQ1 期刊介绍(非官网)

Infectious Diseases And TherapySCIE

国际简称：INFECT DIS THER 参考译名：传染病与治疗

中科院分区
3区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：2193-8229; E-ISSN：2193-6382; 是否OA：开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：ENGLAND; 出版商：Springer Healthcare; 出版语言：English; 出版周期：6 issues per year; 出版年份：2012; 研究方向：Medicine-Microbiology (medical)

评价信息：: 影响因子：4.7; CiteScore指数：8.6; SJR指数：1.351; SNIP指数：1.311

发文数据：: Gold OA文章占比：98.50%; 研究类文章占比：77.78%; 年发文量：144; 自引率：0.0185...; 开源占比：0.9927; 出版撤稿占比：0; 出版国人文章占比：0.04; OA被引用占比：1

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Infectious Diseases And Therapy期刊介绍

Infectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.

期刊简介Infectious Diseases And Therapy期刊介绍

《Infectious Diseases And Therapy》自2012出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间： 6 Weeks
医学
INFECTIOUS DISEASES
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Infectious Diseases And Therapy Cite Score数据

CiteScore：8.6
SJR：1.351
SNIP：1.311

学科类别	分区	排名	百分位
大类：Medicine 小类：Infectious Diseases	Q1	61 / 344	82%
大类：Medicine 小类：Microbiology (medical)	Q1	31 / 140	78%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Infectious Diseases And Therapy 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	3区	INFECTIOUS DISEASES 传染病学	3区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Infectious Diseases And Therapy JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：INFECTIOUS DISEASES	SCIE	Q1	20 / 132	85.2%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：INFECTIOUS DISEASES	SCIE	Q1	32 / 132	76.14%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA96
England21
Italy21
GERMANY (FED REP GER)16
Belgium14
Canada14
CHINA MAINLAND13
France13
Spain13
Netherlands11

本刊中国学者近年发表论文

1、Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study
Author: Xu, Wei; Hu, Qiankun; Chen, Chong; Li, Weixia; Li, Qiang; Chen, Liang

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 487-498. DOI: 10.1007/s40121-022-00738-1
2、Retrospective Analysis of Epidemiology, Risk Factors, and Outcomes of Health Care-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in a Chinese Tertiary Hospital, 2010-2019
Author: Li, Meng; Yang, Shanshan; Yao, Hongwu; Liu, Yunxi; Du, Mingmei

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 473-485. DOI: 10.1007/s40121-022-00732-7
3、Association Between Lactate and 28-Day Mortality in Elderly Patients with Sepsis: Results from MIMIC-IV Database
Author: He, Liudang; Yang, Donghua; Ding, Qiong; Su, Yingjie; Ding, Ning

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 459-472. DOI: 10.1007/s40121-022-00736-3
4、Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19
Author: Meng, Qing; Li, Wujiao; Jiang, Hanfang; Yan, Huimin; Wang, Heping; Ye, Binjun; Zhou, Lintao; Chen, Yunsheng

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 563-575. DOI: 10.1007/s40121-022-00751-4
5、The Association Between Alveolar-Arterial Oxygen Tension Difference and the Severity of COVID-19 in Patients
Author: Xie, Canbin; Deng, Jiayi; Li, Fanglin; Wu, Chenfang; Xu, Min; Yu, Bo; Wu, Guobao; Zhong, Yanjun; Tang, Da; Li, Jinxiu

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 577-587. DOI: 10.1007/s40121-022-00752-3
6、Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients
Author: Weng, Chengzhao; Xie, Rongcheng; Han, Guanjie; Yuan, Ya; Li, Shiqin; Wang, Chao; Wang, Xiaofeng; Jiang, Wei; Jiang, Libo

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 649-662. DOI: 10.1007/s40121-023-00760-x
7、Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults
Author: Chen, Guiling; Li, Nan; Dai, Xiahong; Tu, Shiyan; Shen, Zhenwei; Wu, Kaiqi; Jin, Tinghan; Wu, Jiajun; Peng, Conggao; Sheng, Guoping; Zhu, Mengfei; Tang, Lingling; Li, Lanjuan

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 2, pp. 663-675. DOI: 10.1007/s40121-023-00759-4
8、Effect of Anti-HBs on Mortality Among Resolved HBV Infection: a Population-Based Prospective Cohort Study
Author: Huang, Shuai-Wen; Li, Xi-Tang; Chen, Chen; Ning, Qin; Huang, Jia-Quan

Journal: INFECTIOUS DISEASES AND THERAPY. 2023; Vol. 12, Issue 3, pp. 871-890. DOI: 10.1007/s40121-023-00766-5